1 / 19

Laboratory Automation & Instrumentation Power Protection Systems Case Study Celera Genomics

Laboratory Automation & Instrumentation Power Protection Systems Case Study Celera Genomics. Celera’s Benefits. Lower Operating Cost Increased Productivity Happier Investigators/Managers/Staff Higher Revenue & Investor Potential. The Lab and Operating Environment.

Thomas
Télécharger la présentation

Laboratory Automation & Instrumentation Power Protection Systems Case Study Celera Genomics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Laboratory Automation & Instrumentation Power Protection Systems Case Study Celera Genomics

  2. Celera’s Benefits Lower Operating Cost Increased Productivity Happier Investigators/Managers/Staff Higher Revenue & Investor Potential

  3. The Lab and OperatingEnvironment Key challenges and issues: • Profitability in the laboratory and automation environments • On time delivery of reportable results • Overall customer satisfaction • Internal and external

  4. The Lab and OperatingEnvironment Key issues and distracters: • Instrumentation performance • Human Genome race • Availability and reliability • Environmental conditions

  5. The Laboratory Key issues - Environmental: • Quality of power from the utility • Other equipment sharing the line • Centrifuges • Auto loaders / robotics • Pumps and heaters • Bar code readers (lasers) • Other PCR-DNA Sequencing Instrumentation

  6. The Laboratory Quality of power directly from the utility: Desired waveform

  7. The Laboratory The reality of laboratory and production power: Harmonic distortion and frequency variation waveform is typical

  8. The Lab and OperatingEnvironment Key issues - Environmental: • Challenges for a Laboratory Productivity-Protection System (LPS) • Each application must be qualified • Peak loads • Other instrumentation line interference (transient) • Inrush currents and load (Power) factors • Power connection and distribution • Waveform (Volts, Hz, harmonic distortion, et al)

  9. Franek Technologies, Inc. (FTI) The Leader in Power Protection for Medical and Scientific Instrumentation

  10. Applications • Automation • Biotechnology • Drug discovery • DNA, human Genomics and Proteomics research • Pharmaceutical production • Clinical chemistry • Diagnostic imaging • Immunology and cytometry • Oncology • Hematology and blood banking • FDA 510(k) patient contact applications • Forensics • Scientific research • Other commercial laboratory instrumentation

  11. Key Applications Several Billions in Protected Laboratory and Production Instrumentation • Baxter Healthcare • Over 1,800 LPS placements worldwide • Celera Genomics • 320 LPS placements in a single Lab • Mallinckrodt (Nellcor / Puritan-Bennett) • Over 200 FDA 510(k) Ventilator support – patient contact

  12. Key Applications Several Billions in Protected Laboratory Instrumentation • Perkin Elmer / ABI, DNA & Protein Analyzers • Over 3,000 LPS placements worldwide • Datex Ohmeda, Drager and North American Drager • Over 200 510(k) LPS units for anesthesia work stations

  13. Franek Value • Cutting Edge Technology • Engineered Qualified Application Program • Most Qualified and Experienced of all Power Protection Firms • Laboratory • Pharmaceutical • Healthcare Research • Scientific markets

  14. LPS Economics “LPS Application Rules of Thumb” • LPS systems are very affordable • Service costs are $2,000 / Hr, or more • LPS systems have proven ROI • Instrumentation operating costs drop • Instrumentation availability is very high • Overall productivity is maximized • Instrumentation and internal customer satisfaction performance improves

  15. FTI Case Studies Celera Genomics Corporation race with Human Genome Project ~ Several billions invested Goals • First to patent the human genome – Time Critical Race Strategy: • Develop subscription based business to genome database • Partner with major pharmaceutical clients for drug discovery Challenges: • Maintain genome sequencing focus • Keep the Rockville, MD and Foster City, CA labs operational • Sequence in PE/ABI analyzers as development schedule required • Operate nearly 350 DNA Sequencer systems simultaneously

  16. FTI Case Studies Celera Genomics Corporation race with Human Genome Project ~ Several billions invested Laboratory Challenges and Issues • Keep the Rockville, MD and Foster City, CA labs operational • Sequence in PE/ABI analyzers as development schedule required • Operate nearly 350 DNA Sequencer systems simultaneously • Minimize laboratory infrastructure while maintaining effectiveness Strategy: • FTI Consulted as laboratory power engineering specialists • FTI’s five year partnership with PE/ABI lead to sole source orders Challenges: • LPS system design to assure DNA Sequencer operational integrity • LPS & Lab engineering modifications unique to the lab environment • Delivery and servicing of over 325 LPS units in 9 months

  17. FTI Case Studies Celera Genomics Corporation race with Human Genome Project ~ Several billions invested Celera and PE/ABI Results • Celera claimed victory in genome discovery • Kept Rockville, MD and Foster City, CA labs operational • Established PE/ABI and FTI as key business partners • Researchers provided FTI referrals to all lab types • CDC, NIH, University, Pharmaceutical, Forensic All economic goals for Celera and PE/ABI attained • Estimated savings for Celera at over $24 Million

  18. FTI Case Studies Celera Genomics Corporation Detailed Analysis: FTI cost savings for Celera and PE/ABI (Goals) • Prevented .10 failure / instrument / 24 hour period (minimum) • 350 systems @ 365 days = 127,750 operational days • Potential operational incidents = 12,775 • Down time cost per incident $2,000.00 • Potential down time savings: $25,550,000 Benefit to Cost = 13:1

  19. Engineered Laboratory Instrumentation Protection Systems www.franek-tech.com 800 326 6480 / + 1 714 734 5656

More Related